¹û¶³Ö±²¥ÊÓƵ

​​This collaborative project aims to develop open-access methodological frameworks to guide the development of national and local policies to improve antibiotic prescribing.  

​Global governance on the use of antibiotics is important, but often missing. We need advocacy initiatives, and to remind countries of their global commitment to AMR. A global policy on antimicrobial use/resistance, and implementation of programmes to reduce the inappropriate use of antibiotics are needed to hold governments accountable, and to track progress towards National AMR Action Plans.  

​ â€‹We are using the WHO Essential Medicines List and AWaRe antibiotic book, together with information about the incidence of infections and prevalence of resistance to different antibiotics in countries, to inform models and are engaging with a number of countries for our collaborators to analyse their own data.​ 

Speaker

Senior Lecturer, St George’s, University of London 

Dr. Catrin Moore’s research focuses on antimicrobial resistance, often termed the silent pandemic, which is on the increase globally, and is worse in many low- and middle-income countries (LMICs). Dr. Moore is a microbiologist and was based at the University of Oxford for nearly 25 years working in the Global and Public health arena. Her work has focussed on building capacity in resource poor settings, and she was previously based in Laos and Cambodia building the microbiology laboratory services and research provision in local hospitals. Dr. Moore joined the Big Data Institute in May 2018, where she led the Global Research on AntiMicrobial Resistance (GRAM) project. Partnered with the Institute for Health Metrics and Evaluation (IHME) in Seattle and Tropical Medicine in Oxford, they analysed global data to produce health metrics and geospatial maps on antimicrobial resistance (AMR). They published the first ground-breaking publication to estimate the global burden of AMR in the Lancet in January 2022. Dr Moore is a member of the World Health Organization Advisory Group on Critically Important Antimicrobials (AG CIA) for Human Medicine, a mentor for Fleming Fund Fellows based in Eswatini, and a co-chair for the Impact and Influence committee for the Microbiology Society. 

Now based at St George’s, University of London she works closely with researchers in several LMICs on the AMR Data to Inform Antibiotic guidance and Local Action (ADILA) project and other projects focussing on the burden of AMR and antibiotic exposure in the community. She has work beginning in Uganda to examine the burden of AMR in the community and to understand the data that informs the WHO GLASS surveillance system. She is passionate about reducing the burden of AMR in the community through meaningful, simple, and sustainable interventions such as the use of diagnostic tools, training, and communication in LMICs.